InvestorsHub Logo
Followers 54
Posts 4438
Boards Moderated 0
Alias Born 08/21/2015

Re: tganz post# 20031

Wednesday, 04/19/2017 11:50:52 AM

Wednesday, April 19, 2017 11:50:52 AM

Post# of 74527
I honestly don't know the answer to that question and have no interest in Kasten. I research them because they have the potential to prevent ViaDerma from using the patent-pending technology. There is a reason the Annual Report contains notice of the lawsuit and reference to a claim that Otiko didn't assign technology to Dakota.

Kasten is in transition at this time. Keough may need to resolve his ongoing problems with Otiko before they can go full speed ahead. I give him credit if that is the case.

what happen to kast not even trading sometimes for days with no trading